NAD+ supplements and IV therapy: separating hype from human data

What's this video probably claiming?

Based on the #NAD hashtag and the wellness-forward framing from @white_lotus_wi, this video almost certainly promotes NAD+ as a near-universal fix for energy, aging, brain function, or metabolic health. These creators typically push one of three delivery formats: oral NMN or NR supplements, sublingual NAD+, or IV NAD+ infusions. The pitch usually sounds something like: your NAD+ levels drop as you age, this is why you feel tired and foggy, and replenishing it will reverse that decline. Some creators in this space go further, linking low NAD+ to everything from DNA damage accumulation to neurodegenerative disease. The peptide-adjacent telehealth world has adopted NAD+ as a flagship longevity molecule, and the claims have a way of outrunning the data by several years.

What does the science actually show?

The honest answer is: promising preclinical data, genuinely thin human evidence. NAD+ does decline with age, that part is real. Yoshino et al. (2021, Science) showed that oral NMN supplementation at 250mg/day for 10 weeks improved muscle insulin sensitivity in postmenopausal women with prediabetes, a real finding with real numbers. Dollerup et al. (2018, Nature Communications) tested NR at 2,000mg/day for 12 weeks and found it raised blood NAD+ metabolites but produced no significant change in insulin sensitivity, body composition, or blood pressure in healthy obese men. A 2023 randomized trial by Liao et al. in Nature Aging found NMN improved some physical performance markers in older adults. What these studies do not show is that NAD+ supplementation reverses aging, extends lifespan in humans, or fixes fatigue in healthy people. The rodent data is genuinely exciting. Human trials are small, short, and inconsistent.

Where does the social media noise diverge from clinical reality?

The biggest gap is between preclinical enthusiasm and human clinical outcomes. TikTok creators frequently cite mouse studies where NAD+ precursors extended lifespan or reversed muscle wasting, then imply you will get the same result from a supplement or IV drip. That is not how translation from rodent to human works, and the longevity field has been burned by this assumption repeatedly. IV NAD+ is a specific problem. It is expensive, typically $300-$800 per infusion, and the evidence base for IV delivery over oral is essentially nonexistent in published human trials. The flushing, nausea, and chest tightness during infusions are real and underreported by wellness content. There is also no established reference range for what constitutes clinically low NAD+ in a healthy adult, which makes the sell-the-deficiency framing impossible to verify. Creators also rarely distinguish between NAD+ itself, NMN, and NR, which have different bioavailability profiles and different evidence bases.

What should you actually know?

NAD+ precursor supplementation is not dangerous for most people at studied doses, and some people with specific metabolic conditions may see real benefit, particularly around insulin sensitivity. But the longevity and energy claims being made on platforms like TikTok are significantly ahead of the science. If you are a healthy adult without metabolic dysfunction, the evidence that you will feel meaningfully better from NMN, NR, or IV NAD+ is weak. The FDA does not recognize NAD+ as a treatment for any condition. Compounded NAD+ formulations exist in a regulatory gray zone. Before spending hundreds of dollars on infusions, it is worth asking your provider what outcome you are actually measuring and how you will know if it worked. A provider who cannot answer that question is selling you hope, not medicine.